An Exclusive Oncology Invitation

Please join American Molecular Laboratories for an exciting symposium discussing the rising trends in the development of targeted therapies and immunotherapy in cancer treatment!

A panel of leading experts in oncology, drug development, and personalized medicine will present the latest findings on this exciting topic.

 

Emerging Resistance to Targeted and Immunotherapy in the Treatment of Cancer

6:00 pm Networking and Reception
6:25 pm Introduction by Drs. Sarah Bacus (American Molecular Laboratories) and Yosef Yarden (Weizmann Institute)
6:30 pm “The Curative Potential of Cell Transfer Therapy for Cancer” – Dr. Steven A. Rosenberg
7:00 pm “Response and Resistance to Lung Cancer Therapies” – Dr. Roy Herbst
7:30 pm “Genomic Signatures of Response and Resistance to Cancer Treatment” – Dr. Victor Velculescu
8:00 pm “Roles for Immunotherapy in the Treatment of Breast Cancer” – Dr. Jose Baselga
8:30 pm Questions & Answers followed by Panel Discussion

Panelists’ Perspectives

Panel List

Steven Rosenberg, MD, Ph.D, Chief, Surgery Branch, National Cancer Institute, Bethesda, MD

Roy S. Herbst, MD, Ph.D, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Yale

Victor Velculescu, MD, Ph.D, Co-Director of Cancer Biology, Johns Hopkins Kimmel Cancer Center

Jose Baselga, MD, Ph.D, Physician In Chief, Memorial Sloan Kettering Cancer Center

Location

Saturday, June 4, 2016
6pm – 9pm
Hilton Chicago
Williford Room, 3rd Floor
720 S. Michigan Ave.
Chicago, IL

Space is limited so please reserve a seat through RSVP

RSVP